title: Bladder dysfunction in hereditary spastic paraplegia: a clinical and urodynamic evaluation.
abstract: OBJECTIVE
  Hereditary spastic paraplegia (HSP) is a degenerative central nervous system disorder characterized by progressive spasticity and hyperreflexia of the lower limbs. Often, patients with HSP experience symptoms of voiding dysfunction. Urodynamic evaluations of these patients are rarely reported in the literature and the etiology of voiding dysfunction remains unclear. The present study characterizes lower urinary tract dysfunction in a large series of patients.
  
  
  METHODS
  The medical records of 29 HSP patients who underwent urodynamic evaluation were retrospectively analyzed. The history of lower urinary tract symptoms was noted and the urodynamic findings analyzed.
  
  
  RESULTS
  Urgency was the most dominant complaint (72.4%), followed by frequency (65.5%), urinary incontinence (55.2%) and hesitancy (51.7%). The urodynamic findings showed signs of central neurogenic bladder in 24 patients (82.7%), with detrusor overactivity (DO) in 15 patients (51.7%) and detrusor sphincter dyssynergia (DSD) in 19 (65.5%). Post-void residual (PVR) of >10% of the voided volume was found in 12 patients (41.4%). There were significant relationships between detrusor overactivity and PVR (P=0.005), frequency (P=0.046) and nocturia (P=0.045). Ultrasound examination revealed no upper urinary tract complications.
  
  
  CONCLUSIONS
  Despite the presence of DO and DSD, HSP patients do not seem to have a high risk of developing ultrasonographically-assessed upper urinary tract complications after a mean follow-up of 22 years, contrary to spinal cord injury population. These results may guide practitioners in their decision-making about the appropriate evaluation and treatment of bladder disturbances that accompany hereditary spastic paraplegia.
authors.affiliation: INSERM; UMR-S 864, Bron, France. fourtmary@yahoo.fr
authors.forename: M
authors.initials: M
authors.lastname: Fourtassi
authors.forename: S
authors.initials: S
authors.lastname: Jacquin-Courtois
authors.forename: M C
authors.initials: MC
authors.lastname: Scheiber-Nogueira
authors.forename: A
authors.initials: A
authors.lastname: Hajjioui
authors.forename: J
authors.initials: J
authors.lastname: Luaute
authors.forename: K
authors.initials: K
authors.lastname: Charvier
authors.forename: D
authors.initials: D
authors.lastname: Maucort-Boulch
authors.forename: G
authors.initials: G
authors.lastname: Rode
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015897:Comorbidity; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012307:Risk Factors; D015419:Spastic Paraplegia, Hereditary / Q000175:diagnosis / Q000453:epidemiology*; D001745:Urinary Bladder Diseases / Q000175:diagnosis / Q000453:epidemiology*; D014555:Urination Disorders / Q000175:diagnosis / Q000453:epidemiology*